|
Abstract
Aim: This study aimed to
investigate key genetic variants contributing to prostate cancer and their
functional significance through integrative bioinformatic and molecular
network analyses.
Methodology: GWAS data for
prostate cancer were explored to identify important genetic variants and
underlying biological pathways. Bioinformatic approaches were applied for
enrichment analysis, protein–protein interaction network construction, and
clustering to assess gene interactions. Regulatory mechanisms were examined
through microRNA and transcription factor interaction analyses, with
metabolomic data integrated to assess the impact of genetic variability on
prostate cancer metabolism.
Results: Notable
associations were identified for hsa-miR-2277-5p and hsa-miR-3944-3p,
suggesting potential regulatory significance, although these did not retain
significance following multiple testing correction. Reactome Pathway 2024
analysis identified Abacavir Transmembrane Transport as the most
significantly enriched pathway (adjusted p = 0.00147; odds ratio = 429.33),
alongside additional biologically relevant pathway associations.
Interpretation: This study
highlights key genetic factors and regulatory elements potentially
contributing to prostate cancer susceptibility and progression. The
identified genes, microRNAs, and pathways advance mechanistic understanding
of disease vulnerability and may ultimately inform the development of
biological markers and targeted therapeutic strategies for prostate cancer.
Key
words:
Bioinformatics, GWAS, MicroRNA, Prostate cancer, Pathway enrichment
|